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Success of arterial revascularization determined by
contrast ultrasound muscle perfusion imaging
Daniel Duerschmied, MD,a Philipp Maletzki, MD,a Gabriele Freund, MD,a,b Manfred Olschewski, MSc,c
Christoph Bode, MD,a,b and Christoph Hehrlein, MD,a,b Freiburg, Germany
Background: In the early postoperative evaluation of the success of arterial revascularization, ankle-brachial index (ABI)
and other noninvasive tests lack reliability, especially in patients with incompressible arteries or local edema. Contrast-
enhanced ultrasound (CEUS) imaging of limb muscle perfusion may be an alternative to standard tests if it detects
treatment success reliably.
Methods: We compared a simplified CEUS method with clinical staging, pulse volume recording (PVR), and ABI in
patients with lifestyle-limiting peripheral arterial disease undergoing revascularization by percutaneous transluminal
angioplasty (PTA) or bypass surgery. Patients underwent staging, PVR, ABI, and CEUS before, directly after, and 3 to
5 months after successful PTA (n  20) or successful bypass grafting (n  14). For CEUS, contrast agent was injected
into an antecubital vein, and the time from beginning to peak intensity of contrast enhancement (TTP) in the calf muscle
was measured.
Results: Successful revascularization by both PTA and bypass was associated with a significant improvement in staging,
PVR, ABI, and TTP directly after intervention and at follow-up. Median ABI increased from 0.60 to 0.85 (P  .001)
after PTA and from 0.36 to 0.76 (P .003) after bypass surgery. Median TTP decreased from 45 seconds to 24 seconds
(P .015) and from 30 seconds to 27 seconds (P .041), respectively.McNemar analysis revealed unidirectional changes
in both ABI and TTP (P  .625 after PTA and P  1.000 after bypass surgery), and equivalence analysis showed 95%
confidence intervals within clinical indifference, indicating that TTP was equivalent to standard tests in detecting
successful revascularization.
Conclusions: Contrast ultrasound perfusion imaging of calf muscle after arterial revascularization may be a valuable
alternative to standard noninvasive tests such as ABI or PVR to determine the success of an arterial revascularization.
(J Vasc Surg 2010;52:1531-6.)Peripheral arterial disease (PAD) is associated with a
high mortality due to its generalized character with athero-
sclerotic lesions and ischemic complications not only in
extremity muscles or kidneys but also in myocardium and
brain.1,2 Current guidelines recommend the use of differ-
ent diagnostic tools for the management of patients with
PAD, including ankle-brachial index (ABI), pulse volume
recordings (PVR), duplex ultrasound, and angiography.3
Recently, contrast-enhanced ultrasound (CEUS) was
introduced as a supplementary method by our and other
groups and has since expanded the diagnostic spectrum
with the possibility to quantify perfusion of the end organ
skeletal muscle.4,5 After intravenous injection of a contrast
agent, CEUS allows analysis of the intravascular distribu-
tion of the hyperechogenic agent over time. A simplified
CEUSmethod detected the perfusion deficits in calf muscle
of PAD patients with respect to severity of disease and
degree of collateralization.6 Whether implementation of
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doi:10.1016/j.jvs.2010.07.010CEUS can improve clinical outcome has not yet been
investigated, but it may become valuable, especially in
bed-ridden patients or those with incompressible arteries.
Moreover, CEUS may be useful for monitoring medical or
surgical treatment success or progressive ischemic deterio-
ration in patients at risk for critical limb ischemia. The
evaluation of calf muscle perfusion with CEUS may help to
predict outcomes of exercise training after an intervention.
In patients with diabetes mellitus or atherosclerosis, we and
others previously quantified impaired microcirculation at
rest and capillary recruitment during exercise reliably by
CEUS.7,8
Guideline-recommended treatment of lifestyle-limiting
PAD consists of supervised exercise programs, pharmaco-
logical therapy, and — in case of treatment failure, inflow
disease (ie, occlusive pelvic lesions), or critical limb isch-
emia — endovascular or surgical revascularization.3 The
success of revascularization is routinely assessed by a com-
bination of clinical examination (improvement of symp-
toms, pulse palpation), treadmill walking distance, ABI,
PVR, duplex ultrasound (particularly recommended for
postoperative vein graft follow-up), and, if needed, angiog-
raphy. Here, we investigate intra-individual changes in
CEUS compared with clinical staging, PVR, and ABI be-
fore, shortly after, and 3 to 5 months after a successful
arterial revascularization. The aim of this study was to test
whether the quantification of muscle perfusion of the lower
limb by CEUS detects the success of revascularization and
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standard tests.
MATERIALS AND METHODS
Study design. This single-center study compares
CEUS with clinical staging, PVR, and ABI in patients with
lifestyle-limiting PAD who successfully underwent non-
randomized lower extremity revascularization either by
percutaneous transluminal angioplasty (PTA) or bypass
surgery. All patients underwent these diagnostic tests be-
fore, directly after, and in follow-up after revascularization
(Fig 1). The protocol complies with the Declaration of
Helsinki and was approved by the Ethics Committee of the
University of Freiburg, Germany. The data collection was
planned prospectively and registered on clinicaltrials.gov
(NCT00424450). All participants gave informed consent.
Study participants were recruited consecutively from the
local Departments of Internal Medicine, Radiology, and
Vascular Surgery fromOctober 16, 2006 through October
4, 2007, and were considered eligible for enrollment if they
were 18 years of age. All participants had to present with
persistent lifestyle-limiting, symptomatic PAD (Fontaine
stage IIA to IV) and at least one80% stenosis with a peak
velocity ratio intrastenotic/prestenotic 4.0 or an occlu-
sion of an iliac, femoral, or popliteal artery in duplex
ultrasound. Preinterventional planning was completed with
conventional, computed tomographic, or magnetic reso-
nance angiography according to the treating physician’s
decision. Patients were assigned to either PTA or bypass
grafting according to the treating physician’s recommen-
dation, and all patients gave informed consent to this
treatment.
Success of the revascularization was confirmed by du-
Fig 1. Study population. Patients with lifestyle-limiting periph-
eral arterial disease (PAD) and previous conservative treatment
failure were assigned to treatment by percutaneous transluminal
intervention (PTA) or bypass surgery in a nonrandomized fashion.
ABI, Ankle-brachial index; CEUS, contrast-enhanced ultrasound;
PVR, pulse volume recording.plex ultrasound with a decrease in peak velocity ratio intra-stenotic/prestenotic 2.0 of the target lesion(s) or pres-
ence of a fully perfused bypass without relevant stenosis at
both anastomoses (peak velocity ratio intrastenotic/prest-
enotic 2.0).9 Exclusion criteria were acute or chronic
heart failure (New York Heart Association IV), pulmonary
hypertension with a systolic pulmonary arterial pressure
55 mm Hg, and an initial ABI 1.3.
Standard methods. Patient history and constant work-
load treadmill test (3.5 km/h  2.2 mph; 12.5% grade)
were used for PAD staging according to Fontaine.3 Fon-
taine stage I was defined by no limiting symptoms present,
stage IIA by a maximal walking distance200m, stage IIB
by a maximal walking distance 200 m, stage III by
ischemic rest pain, and stage IV by presence of ulceration or
gangrene. ABI was obtained by dividing the higher ankle
systolic pressure (dorsalis pedis or tibialis posterior) —
which was proposed to be superior to the lower pressure for
addressing limb perfusion — by the higher of the two
brachial pressures.10 PVRs of calf arteries were obtained
with a plethysmograph/oscillograph (Gutmann, Euras-
burg a.d. Loisach, Germany). PVR reduction was arbi-
trarily classified as high/mid-high/middle/low-mid/low/
none according to 0% to 18%/19% to 36%/37% to 54%/
55% to 76%/77% to 84%/85% to 100% of mean amplitude
height in 20 healthy control subjects.
Contrast-enhanced ultrasound. The LOGIQ 9 ul-
trasound system (GE Healthcare Technologies, Milwau-
kee, Wisc) with a 3-7 MHz wide band linear transducer
(7L-probe, GE Healthcare Technologies) was used in con-
trast mode: Coded Phase Inversion Technology with a low
mechanical index of 0.14 (acoustic output 4%), depth 4 cm,
one focus zone at 2.75 cm, transmission frequency 6MHz,
dynamic range 72 dB, pulse repetition interval 0.5 s, grey
map K, B-(Brightness-)Mode amplification 30. An area
between the proximal and medial third of gastrocnemius
and soleus muscle in an axial plane not showing any bone
tissue was chosen in B-mode after 10 minutes at rest in a
Fig 2. Simplified CEUS procedure. Calf muscle was visualized in
a supine position at rest and a 4-cm diameter, round region of
interest (ROI; upper inset) was placed over muscle tissue avoiding
large vessels and bone. Contrast agent was injected into an ante-
cubital vein, and distribution kinetics of contrast enhancement
(lower inset) were detected after first appearance in the ROI.supine position (Fig 2). Duplex mode allowed localization
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round) placement avoiding these vessels.
A bolus of 4.8 mL Sonovue solution (sulphur hexaflu-
ouride, Bracco International B.V., Amsterdam, The Neth-
erlands) was injected into an antecubital vein using a 20-
gauge venous catheter, followed immediately by a 5-mL
saline bolus to flush the injection line. Recording a
2-minute loop in contrast mode allowed analysis of contrast
kinetics after the bolus entered the ROI. The time to peak
(TTP) contrast intensity was measured as the duration from
the beginning of the increase in acoustic intensity until its
peak in the ROI. This parameter was found to be highly
reproducible and independent of cardiac output in PAD
patients.6 The analysis of loops was carried out in a blinded
way and a three-times averaging was applied to minimize
artefacts.
Statistical analysis. Based on previously published
data,5,6 a power calculation for an alpha 5% with a power
of 80% and an assumed standard deviation of 10 seconds
yielded a necessary sample size of 16 to detect a mean
decrease in TTP of 7.5 seconds (G*Power 3.0.10,Heinrich
Heine University, Duesseldorf, Germany). We envisioned
including 20 patients in each group, with the goal to keep
a sample size of at least 16 at follow-up. Patient characteris-
tics are presented as mean and standard deviation or median
and range for quantitative data and as absolute frequency
and percentage for qualitative data.Mann-WhitneyU test and
Fisher’s exact test were used to compare quantitative and
nominal baseline variables (Table). Wilcoxon-rank test was
applied to compare the serial examinations within each study
group (Fig 3). McNemar test was used for comparison of
value changes over time (Fig 4A). Equivalence analysis was
carried out according to Consolidated Standards of Report-
ing Trials Statement recommendations (Fig 4B):11 two-
sided 95% confidence intervals (CIs) of the difference
between percentage of correctly detected successful revas-
cularization with TTP and standard parameters were calcu-
lated. Inclusion of zero was considered the primary crite-
rion for equivalence, and a zone of clinical indifference was
defined between 20% and 20%, according to previously
Table. Baseline clinical characteristics
Variable/parameter
PTA
(n  20)
Bypass
(n  14) P
Age (years) mean  SD 64  12 66  12 .666
Median, range 62 (45-87) 67 (47-82)
Male gender 12 (60) 7 (50) .728
Lesion location: multiple/
pelvic/femoral/popliteal 10/5/4/1 5/4/5/0
Smokers 16 (80) 8 (57) .252
Median pack years (range) 44 (15-80) 44 (20-70)
Hypertension 13 (65) 10 (71) 1.000
Dyslipidemia 11 (55) 8 (57) 1.000
Diabetes mellitus 3 (15) 5 (36) .228
PTA, Percutaneous translumninal angioplasty.
Number of patients (%), unless otherwise indicated.reported differences between ABI and PVR.12 All statisticaltests were two-sided and a P value of .05 was interpreted
to denote statistical significance. Statistical analysis was
performed using SPSS Software, 17.0 (SPSS Inc, Chicago,
Ill).
RESULTS
Patient enrollment. Initially, 55 patients with lifestyle-
limiting PADwere screened (Fig 1). Thirteen patients were
excluded because continuation of conservative treatment
was preferred, three patients switched treatment centers,
two patients withdrew informed consent, and, in three
patients, revascularization was not successful (one of whom
finally underwent lower leg amputation). Twenty patients
assigned to PTA and 14 patients assigned to bypass were
included, and PAD staging, PVR, ABI, and CEUS were
performed as described below. Revascularization was com-
pleted in all patients within 6 weeks after this initial exam-
ination, and a second examination was performed within 4
weeks after revascularization. Follow-up examination was
performed 3 to 5 months after revascularization. In the
PTA group, four patients were lost to follow-up (one
developed severe restenosis, two refused the outpatient
follow-up examination, and one patient died). After bypass
surgery, two patients underwent amputation, and five re-
fused the outpatient follow-up.
Noninvasive assessment of successful arterial reva-
scularization. Distribution of age, gender, and arterio-
sclerotic risk factors was not significantly different between
the groups (Table). Median Fontaine stage in the PTA
group was IIB (range, IIA-IV) before revascularization and
improved significantly to stage IIA (range, I-IV) after re-
vascularization (Fig 3A). After bypass, median Fontaine
stage improved significantly from III (range, IIA-IV) to IIB
(range, I-IV). Clinical stage further improved in both
groups at follow-up. Median amplitude reduction in PVR
improved significantly from middle (none-high) to none
(none-middle-high) after PTA and from middle-high
(middle-high) to none (none-middle-high) after bypass
(Fig 3B). Median ABI improved significantly from 0.60
(range, 0.0-1.08) to 0.85 (range, 0.50-1.47; P  .001)
after angioplasty and to 0.94 (range, 0.56-1.84) at fol-
low-up (Fig 3C). In the bypass group, median ABI was
0.36 (range, 0.0-0.70) before and 0.76 (range, 0.0-1.11)
after surgery (P .003). At follow-up, median ABI further
increased to 1.00 (range, 0.61-1.18), but the difference
compared with after surgery was not significant (P .204).
None of the study participants reported any side effects
of CEUS. The mean examination duration was 5.5 minutes
(Fig 2); the total duration including patient preparations
and image analysis was 19 minutes. In the PTA group,
median TTP was 45 seconds (range, 17-73 seconds) before
and 24 seconds (range, 12-82 seconds) after the interven-
tion (P .015). At follow-up, median TTP was 22 seconds
(range, 16-63 seconds) in this group. After bypass surgery,
median TTP decreased from 30 seconds (range, 17-75
seconds) to 27 seconds (range, 16-42 seconds; P  .041)
directly, and to 21 seconds (range, 12-30 seconds) 3 to 5
months after surgery. Taken together, all parameters
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ization and further improvement at follow-up.
Comparison of noninvasive PAD tests. While all
standard parameters and TTP improved, it was not clear
whether all parameters performed comparably well in cor-
rectly detecting the successful revascularization. A McNemar
analysis comparing ABI and TTP showed no significant
difference in revealing improvement after PTA (P  .625)
or bypass (P  1.0; Fig 4A). One PTA patient was misdi-
agnosed (ie, the success of revascularization was not re-
flected correctly) by both ABI and TTP, and one PTA
patient and two bypass patients were misdiagnosed by ABI.
Three PTA patients and three bypass patients were misdi-
agnosed by TTP.
We next asked whether TTP was equivalent to the
other parameters in detecting the successful revasculariza-
tion directly after the procedure in the whole study popu-
lation (n  34). The data sets could be combined because
neither TTP (P  .545) nor ABI (P  .359), PVR (P 
Fig 3. Time from beginning to peak intensity of con
parameters all improved after successful revascularizatio
recording (PVR) amplitude reduction (B), ankle-brachi
directly after revascularization (post), and at follow-up. A
median, box, interquartile range, whiskers, range, circ
box-lengths from box..986), or Fontaine stage (P  .323) were significantlydifferent between the PTA group and the bypass group. An
equivalence analysis showed that all two-sided 95% CIs
included zero (Fig 4B): The difference of percentages of
correctly detected successful revascularization between
TTP and PVR was9% (95% CI,18 to 0), between TTP
and PAD stage was 12% (95% CI, 0 to 23), and between
TTP and ABI was 9% (95% CI, 18 to 0). The range of
the CI was within the predefined zone of clinical indiffer-
ence for the comparisons TTP/PVR and TTP/ABI and
left that zone in the positive direction for the comparison
TTP/PAD stage.
DISCUSSION
Although optimal management of PAD requires reli-
able diagnostic tools, the best approach for surveillance
after revascularization has not been investigated in random-
ized clinical outcome trials.9 Primarily based on observa-
tional studies, current guidelines recommend physical ex-
amination, ABI, toe pressures, and duplex ultrasound for
enhancement (TTP) in the calf muscle and standard
inical staging according to Fontaine (A), pulse volume
ex (ABI; C), and TTP (D) were assessed before (pre),
alues for comparison to preintervention. Horizontal bar,
tlier 1.5 box-lengths from box, asterisk, outlier 4trast
n. Cl
al ind
ll P v
le, ousurveillance after arterial interventions.3,13,14 Some authors
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All of these methods have certain limitations, and none of
them evaluates muscle perfusion. Expanding the diagnostic
spectrum is desirable because early detection of perfusion
deficits may translate into more aggressive treatment and
better outcome. We therefore sought to compare the novel
Fig 4. Simplified contrast ultrasoundmuscle perfusion imaging is
equivalent to standard methods in detecting successful revascular-
ization. Ankle-brachial index (ABI) and time to peak intensity
(TTP) performed not significantly different in detecting interven-
tion success after transluminal angioplasty (circles, upper P value)
or bypass (grey diamonds, lower P value) in a McNemar analysis
(A). Equivalence analysis of the overall study population directly
after revascularization (B). Two-sided 95% confidence intervals of
subtraction of % correctly detected successful revascularization
with pulse volume recording (PVR), PAD Fontaine stage, and ABI
from % correctly detected with TTP are shown by horizontal bars.
Dashed lines depict the predefined zone of clinical indifference.method of CEUS to these standard methods.Duplex ultrasound is widely recommended for directly
detecting restenosis, which occurs in up to one-third of
patients after PTA.9,14,15 We used duplex ultrasound to
verify the success of revascularization in all included study
patients. ABI is frequently used and validated as a screening
method to detect PAD, but it is false-high in patients with
incompressible arteries or subclavian stenoses and, when
taken at rest, it may underestimate PAD severity.12 Stan-
dardized exercise is often impossible after surgery and in
patients with severe PAD, limiting exercise testing. It is also
not clear which ABI method is best for surveillance after
revascularization. Despite its high validity for detecting
PAD, variability between observers in ABI measurement
(center effect) and reduced sensitivity in patients with post-
interventional edema have been reported.10,16-18 The
CEUS method described here does not depend on vessel
compression, exercise testing, or absence of edema.
We compared changes in clinical staging, PVR, and
ABI after successful revascularization and at follow-up (3 to
5 months) to changes in simplified CEUS. We character-
ized the distribution kinetics of ultrasound contrast agent
within the muscle after the bolus had entered the calf
muscle5,6 without replenishment kinetics after bubble de-
struction or exercise testing.4 Fontaine stage, PVR ampli-
tude reduction, ABI, and TTP all significantly improved
after successful revascularization and further improved at
follow-up. While there was no overlap in the interquartile
ranges between before and after intervention in the distri-
bution of ABI values, there was overlap in TTP values. We
therefore asked whether TTP was inferior or equivalent to
ABI in detecting the successful revascularization. Both
McNemar and equivalence analysis demonstrated that TTP
was equivalent to ABI in this population. TTP was also
equivalent to clinical staging and PVR in correctly revealing
the effective intervention.
The main limitation of this pilot study is its small sample
size. After screening 55 patients, the power calculation-
defined goal of including 20 patients after intervention and
re-examining 16 patients at follow-up was only achieved in
the PTA group. Conservative statistical testing was applied
to account for the loss to follow-up, and even the smaller
group of bypass patients showed significant improvement
in all parameters. Confirmation of our results in larger
studies will be necessary before CEUS enters clinical rou-
tine. A larger study will allow inclusion of high enough
numbers of patients with incompressible arteries or pro-
nounced postoperative edema and will enable investigation
of whether CEUS is superior to standard tests in these
subgroups.
In conclusion, clinical staging, PVR, ABI, and CEUS
all correctly detected the success of a peripheral arterial
revascularization in most patients. Measuring the TTP by a
rapid and easy to perform CEUS method was equivalent to
clinical staging, PVR, and ABI.
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